Valirx - VAL201 Clinical Trials
VAL
Mon, 18 Dec 2017, 12:30 GMT
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Industry: Health Care
Contact: +44 (0)2476 796496
Barling Way
https://www.valirx.com/
Dr George Morris, COO of Valirx, discusses the latest announcement on VAL201 and how the company is able to proceed after receiving the approval for the acceleration of the trial and to substantially escalate the dose, which is a pivotal and substantial breakthrough for their lead compound.
